Rachel S Wightman1, Brendan Jacka2, Julia Uber3, Michelle McKenzie4, Neha G Reddy5, Roger Winters5, Lee Ann Jordison Keeler6, Elizabeth A Samuels6. 1. Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, 55 Claverick St, Providence, RI 02903, United States of America. Electronic address: Rachel_wightman@brown.edu. 2. Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, United States of America. 3. Rhode Island Hospital, 593 Eddy St. Providence, RI, 02903, United States of America. 4. COBRE on Opioids and Overdose/Rhode Island Hospital, 164 Summit Ave (1125 N. Main Bldg), Providence, RI 02906, United States of America. 5. The Warren Alpert Medical School of Brown University, 222 Richmond St, Providence, RI 02903, United States of America. 6. Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, 55 Claverick St, Providence, RI 02903, United States of America.
Abstract
INTRODUCTION: An ED visit for opioid overdose may be a person's only contact with the medical and behavioral health care systems and is an important opportunity to reduce risk of subsequent overdose and death. While ED initiatives to engage people with opioid use disorder (OUD) are being increasingly implemented, there are significant gaps in the receipt of services at the time of the ED encounter. METHODS: This is a retrospective cohort study of an outreach pilot project providing real-time telehealth delivered buprenorphine initiation and referral to community harm reduction and addiction treatment services via a follow up telephone call to patients after an ED visit for an opioid overdose. RESULTS: From January 2020 to April 2021 there were 606 patients with an ED visit for an opioid overdose eligible for a callback. Of the 606 eligible patients, 254/645 (42%) patients could be contacted and accepted service and/or treatment referrals. Fifteen patients were connected same-day to a buprenorphine prescriber for a telehealth encounter and, of connected patients, nine received a buprenorphine prescription. CONCLUSION: A post-ED follow up telephone call protocol is an opportunity to improve treatment engagement and access to buprenorphine for patients at high risk for opioid overdose and death.
INTRODUCTION: An ED visit for opioid overdose may be a person's only contact with the medical and behavioral health care systems and is an important opportunity to reduce risk of subsequent overdose and death. While ED initiatives to engage people with opioid use disorder (OUD) are being increasingly implemented, there are significant gaps in the receipt of services at the time of the ED encounter. METHODS: This is a retrospective cohort study of an outreach pilot project providing real-time telehealth delivered buprenorphine initiation and referral to community harm reduction and addiction treatment services via a follow up telephone call to patients after an ED visit for an opioid overdose. RESULTS: From January 2020 to April 2021 there were 606 patients with an ED visit for an opioid overdose eligible for a callback. Of the 606 eligible patients, 254/645 (42%) patients could be contacted and accepted service and/or treatment referrals. Fifteen patients were connected same-day to a buprenorphine prescriber for a telehealth encounter and, of connected patients, nine received a buprenorphine prescription. CONCLUSION: A post-ED follow up telephone call protocol is an opportunity to improve treatment engagement and access to buprenorphine for patients at high risk for opioid overdose and death.
Authors: Pamela Leece; Cynthia Chen; Heather Manson; Aaron M Orkin; Brian Schwartz; David N Juurlink; Tara Gomes Journal: Ann Emerg Med Date: 2019-09-24 Impact factor: 5.721
Authors: Joseph A Boscarino; H Lester Kirchner; James M Pitcavage; Vijay R Nadipelli; Naoko A Ronquest; Michael H Fitzpatrick; John J Han Journal: Subst Abuse Rehabil Date: 2016-09-16
Authors: William E Soares; Edward R Melnick; Bidisha Nath; Gail D'Onofrio; Hyung Paek; Rachel M Skains; Lauren A Walter; Martin F Casey; Anthony Napoli; Jason A Hoppe; Molly M Jeffery Journal: Ann Emerg Med Date: 2021-03-19 Impact factor: 5.721